HPV-ASSOCIATED OROPHARYNGEAL CANCER (A CLINICAL CASE)


Cite item

Full Text

Abstract

In recent years, human papillomavirus (HPV)-related oropharyngeal tumors have been more frequently detected in the world. Their proportion is 20 to 90% depending on the spread of smoking and the rate of alcohol consumption in the country conducting a study. On the other hand, the proportion of HPV-related squamous cell carcinoma of the oral and pharyngeal mucosae is higher in the countries loyal to sexual norms. According to recent data, HPV-related oropharyngeal cancer should be considered as an individual nosological entity characterized by a tendency to regional metastases generally in relatively small primary tumors and by a high sensitivity to chemotherapy and radiotherapy. The paper describes the experience in successfully treating a 56-year-old patient with locally advanced oropharyngeal cancer and HPV infection.

About the authors

A. R. Gevorkov

Herzen Moscow Oncology Research Institute, Ministry of Health and Social Development of Russia

Email: mnioi@mail.ru
мл. науч. сотр. отд-ния высоких технологий лучевой терапии

A. V. Boiko

Herzen Moscow Oncology Research Institute, Ministry of Health and Social Development of Russia

A. V. Chernichenko

Herzen Moscow Oncology Research Institute, Ministry of Health and Social Development of Russia

S. L. Daryalova

Herzen Moscow Oncology Research Institute, Ministry of Health and Social Development of Russia

L. E. Zavalishina

Herzen Moscow Oncology Research Institute, Ministry of Health and Social Development of Russia

A. A. Ryazantseva

Herzen Moscow Oncology Research Institute, Ministry of Health and Social Development of Russia

V. V. Sokolov

Herzen Moscow Oncology Research Institute, Ministry of Health and Social Development of Russia

A. A. Gladyshev

Herzen Moscow Oncology Research Institute, Ministry of Health and Social Development of Russia

References

  1. Киселев Ф. Л. // Вопр. вирусол. — 1997. — Т. 42, № 6. — С. 248—251.
  2. Поляков П. Ю. Возможности управления тканевой радиочувствительностью в клинической онкологии: Автореф. дис.. д-ра мед. наук. — Обнинск, 2009.
  3. Applebaum K. M., Furniss C. S., Zeka A. et al. // J. Natl. Cancer Inst. — 2007. — Vol. 99. — P. 1801—1810.
  4. Benevolo M., Mottolese M., Marandino F. et al. // J. Clin. Cancer Res. — 2007. — Vol. 26, N 4. — P. 609—612.
  5. Dalianis T., Näsman A., Attner P. et al. // 25-th International papillomavirus conference. — Malmö, Sweden, 2009. — Abstr. O-17.04.
  6. HPV and other infectious agents in cancer: opportunities for prevention and public health / Eds H. Krueger et al. — New York: Oxford University Press, 2010.
  7. Jemal A., Siegel R., Ward E. et al. // Cancer J. Clin. — 2009. — Vol. 59, N 4. — P. 225—249.
  8. Kjaer S. K., Chackerian B., van den Brule A. J. et al. // Cancer Epidemiol., Biomarkers Prev. — 2001. — Vol. 10, N 2. — P. 101—106.
  9. Kreimer A. R., Clifford G. M., Boyle P., Franceschi S. // Cancer Epidemiol. Biomarkers Prev. — 2005. — Vol. 14. — P. 467—475.
  10. Nasman A., Attner P., Hammarstedt L. et al. // Int. J. Cancer. — 2009. — Vol. 125. — P. 362—366.
  11. Rintala M., Grenman S., Puranen M. et al. // J. Clin. Virol. — 2006. — Vol. 35, N 1. — P. 89—94.
  12. Scully C. // Br. Dent. J. — 2005. — Vol. 199, N 4. — P. 203—207.
  13. Shanthi M. // Lancet Oncol. — 2010. — Vol. 11. — P. 781—789.
  14. Shiboski C. H., Schmidt B. L., Jordan R. C. // Cancer. — 2005. — Vol. 103. — P. 1843—1849.
  15. zur Hausen H. // Proc. Assoc. Am. Physicians. — 1999. — Vol. 111, N 6. — P. 581—587.
  16. zur Hausen H. Infections causing human cancer. — Heidelberg: Wiley-VCH, 2006.

Copyright (c) 2012 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies